Opinion: Gene patenting and medical research: a view from a pharmaceutical company

TitleOpinion: Gene patenting and medical research: a view from a pharmaceutical company
Publication TypeJournal Article
Year of Publication2004
AuthorsStott, M, Valentine, J
JournalNature Reviews Drug Discovery
Volume3
Issue4
Pagination364-368
Type of ArticleArticle
Publication Languageeng
ISSN Number14741776
Accession Number12728644
KeywordsDrug , Drugs , MEDICINE , PATENTS , Pharmaceutical
AbstractIn this article the authors seek to evaluate the impact of gene patenting objectively by examining, in overall terms, whether there has been a net cost or benefit to medical research from gene patenting.
NotesStott, Mike 1; Email Address: jill.b.valentine@gsk.com Valentine, Jill 1; Email Address: mike.j.stoll@gsk.com; Affiliation: 1: Corporate Intellectual Property, Glaxo Smith Khine plc, 980, Great West Road, Brentford, Middlesex, TW8 9GS, UK.; Source Info: Apr2004, Vol. 3 Issue 4, p364; Subject Term: PHARMACEUTICAL industry; Subject Term: PATENTS; Subject Term: MEDICINE -- Research; Subject Term: DRUGS -- Research; Subject Term: DRUGS -- Design; Subject Term: DRUG development; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); NAICS/Industry Codes: 325412 Pharmaceutical Preparation Manufacturing; Number of Pages: 5p; Document Type: Article
DOI10.1038/nrd1348
Full Text

Discipline: 

Subject: 

Publication: